ORIG3N
Boston
About ORIG3N
ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases with targets in heart, liver, and neurodegenerative indications. It was founded in 2014 and is based in Boston, Massachusetts.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $76.2M
- Last round: Series Unknown (Sep 2020)
- Website: orig3n.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical, Personal Health
Social Profiles
Canonical: https://fsome.com/organization/orig3n-60081 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.